European Heart Journal Advance Access published online on September 23, 2008
European Heart Journal, doi:10.1093/eurheartj/ehn421
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials
1 Department of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA
2 Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA
3 VA Boston Healthcare System and Brigham and Womens Hospital, 75 Francis Street, Boston, MA 02115, USA
Received 29 April 2008; revised 21 July 2008; accepted 29 August 2008.
* Corresponding author. Tel: +1 617 525 9307, Fax: +1 617 732 7134, Email: dlbhattmd{at}alum.mit.edu
Aims: Adjunctive thrombectomy and embolic protection devices in acute myocardial infarction have been extensively studied, although outcomes have mainly focused on surrogate markers of reperfusion. Therefore, the effect of adjunctive devices on clinical outcomes is unknown. This study sought to determine whether the use of a thrombectomy or embolic protection device during revascularization for acute myocardial infarction reduces mortality compared with percutaneous coronary intervention (PCI) alone.
Methods and results: The Cochrane and Medline databases were searched for clinical trials that randomized patients with ST-elevation acute myocardial infarction to an adjuvant device prior to PCI compared with PCI alone. Devices were grouped into catheter thrombus aspiration, mechanical thrombectomy, and embolic protection. There were a total of 30 studies with 6415 patients who met our selection criteria. Over a weighted mean follow-up of 5.0 months, the incidence of mortality among all studies was 3.2% for the adjunctive device group vs. 3.7% for PCI alone (relative risk, 0.87; 95% confidence interval, 0.67–1.13). Among thrombus aspiration studies, mortality was 2.7% for the adjunctive device group vs. 4.4% for PCI alone (P = 0.018), for mechanical thrombectomy, mortality was 5.3% for the adjunctive device group vs. 2.8% for PCI alone (P = 0.050), and for embolic protection, mortality was 3.1% for the adjunctive device group vs. 3.4% for PCI alone (P = 0.69).
Conclusion: Catheter thrombus aspiration during acute myocardial infarction is beneficial in reducing mortality compared with PCI alone. Mechanical thrombectomy appears to increase mortality, whereas embolic protection appears to have a neutral effect.
Key Words: Acute coronary syndrome ST-elevation myocardial infarction Meta-analysis Mortality Major adverse cardiac events Thrombectomy Embolic protection Thrombus aspiration
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. G. Kushner, M. Hand, S. C. Smith Jr, S. B. King III, J. L. Anderson, E. M. Antman, S. R. Bailey, E. R. Bates, J. C. Blankenship, D. E. Casey Jr, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J. Am. Coll. Cardiol., December 1, 2009; 54(23): 2205 - 2241. [Full Text] [PDF] |
||||
![]() |
A. Prasad, G. W. Stone, D. R. Holmes, and B. Gersh Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The "Dark Side" of Reperfusion Circulation, November 24, 2009; 120(21): 2105 - 2112. [Full Text] [PDF] |
||||
![]() |
G. Heusch, P. Kleinbongard, D. Bose, B. Levkau, M. Haude, R. Schulz, and R. Erbel Coronary Microembolization: From Bedside to Bench and Back to Bedside Circulation, November 3, 2009; 120(18): 1822 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Steg and G. Ducrocq Devices to protect against embolization during primary angioplasty for ST-segment elevation myocardial infarction: the good, the bad and the ugly Eur. Heart J., December 2, 2008; 29(24): 2953 - 2954. [Full Text] [PDF] |
||||


